Participants on ‘metformin combined with other diabetes medications’ were most likely to use gliclazide, followed by insulin and sitagliptin and had lower HDL and were more likely to have hypertension and polypharmacy and to use statins, compared to the other groups. The gene discussed is INS; the disease is diabetes mellitus.